Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala

American Journal of Tropical Medicine and Hygiene

Volumn 65, Issue 5, 2001, Pages 466-470

  Arana, B A ^a   Mendoza, C E ^a   Rizzo, N R ^a   Kroeger, A ^a  

^a UNIVERSIDAD DEL VALLE DE GUATEMALA   (Guatemala)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE; METHYLBENZETHONIUM CHLORIDE; PAROMOMYCIN; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GUATEMALA; HUMAN; MAJOR CLINICAL STUDY; MALE; OINTMENT; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN LEISHMANIASIS;

EID: 0035211329     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2001.65.466     Document Type: Article

References (28)

1. Chemotherapy for leishmaniasis: Biochemical mechanisms, clinical efficacy, and future strategies
2. Randomised controlled trial of aminosidine (paromomycin) upsilon sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India
3. Medicinal plants in the fight against leishmaniasis
4. Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis
5. A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment
6. A randomized, placebo-controlled trial of a two week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran
7. Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin
8. Leishmania major: Histopathologic responses before and after topical treatment in experimental animals
9. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: A double-blind control study
10. Topical treatment of cutaneous leishmaniasis in Belize: In vitro and in vivo studies with Leishmania mexicana
11. Topical treatment of American cutaneous leishmaniasis with paromomycin and methylbenzethonium chloride, a clinical study under field conditions in Ecuador
12. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: Controlled study
13. Cutaneous leishmaniasis in Guatemala: Comparison of diagnostic methods
14. Cutaneous leishmaniasis in Guatemala: Isoenzyme characterization of isolates from humans
15. Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala
16. Placebo controlled clinical trail of sodium stibogluconate (Pentostam) vs. ketoconazole for cutaneous leishmaniasis in Guatemala
17. Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate
18. Antileishmanial activity of methylbenzethomiun chloride
19. Topical chemotherapy of cutaneous leishmaniasis
20. A controlled clinical trial comparing the effectiveness of two topical treatments containing paromomycin vs. glucantime for the New World cutaneous leishmaniasis in Ecuador
21. Efficacy of a short course (10 days) of high-dose meglumine antimonate with or without interferon-γ in treating cutaneous leishmaniasis in Guatemala
22. Consecuencias enconómicas de la leishmaniasis cutánea en pacientes tratados en Trujillo, Area Andina de Venezuela
23. Recurrent lesions in human Leishmania braziliensis infection - Reactivation or reinfection?
24. Use of PCR on lymph-node samples as test of cure of visceral leishmaniasis
25. Use of the polymerase chain reaction to assess the success of visceral leishmaniasis treatment
26. A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey
27. A double blind clinical trial of treatment of cutaneous leishmaniasis with paromomycin ointment